Engelen W - Search Results

1

Four cases of red blood cell aplasia in association with the use of mycophenolate mofetil in renal transplant patients.

Engelen W, Verpooten GA, Van der Planken M, Helbert MF, Bosmans JL, De Broe ME. Engelen W, et al. Clin Nephrol. 2003 Aug;60(2):119-24. doi: 10.5414/cnp60119. Clin Nephrol. 2003. PMID: 12940614

2

Platelet prothrombinase activity, a final pathway platelet procoagulant activity, is overexpressed in type 1 diabetes: no relationship with mean platelet volume or background retinopathy.

van der Planken MG, Vertessen FJ, Vertommen J, Engelen W, Berneman ZN, De Leeuw I. van der Planken MG, et al. Among authors: engelen w. Clin Appl Thromb Hemost. 2000 Apr;6(2):65-8. doi: 10.1177/107602960000600202. Clin Appl Thromb Hemost. 2000. PMID: 10775023 Free article.

3

Effects of long-term supplementation with moderate pharmacologic doses of vitamin E are saturable and reversible in patients with type 1 diabetes.

Engelen W, Keenoy BM, Vertommen J, De Leeuw I. Engelen W, et al. Am J Clin Nutr. 2000 Nov;72(5):1142-9. doi: 10.1093/ajcn/72.5.1142. Am J Clin Nutr. 2000. PMID: 11063441 Clinical Trial.

4

Insulin antibodies before and 1 year after the change-over from U40 to U100 insulin preparations in Belgium.

Engelen W, Van Gaal L, De Leeuw I. Engelen W, et al. Acta Clin Belg. 1994;49(6):262-7. doi: 10.1080/17843286.1994.11718402. Acta Clin Belg. 1994. PMID: 7871932

5

Effect of intensive i.v. + oral magnesium supplementation on circulating ion levels, lipid parameters and metabolic control in Mg-depleted insulin-dependent diabetic patients (IDDM).

De Leeuw I, Engelen W, Vertommen J, Nonneman L. De Leeuw I, et al. Among authors: engelen w. Magnes Res. 1997 Jun;10(2):135-41. Magnes Res. 1997. PMID: 9368234 Clinical Trial.

6

Epidemiology of microalbuminuria in type 1 diabetic patients (IDDM) in the Antwerp University Hospital.

Bouten A, Engelen W, De Leeuw I. Bouten A, et al. Among authors: engelen w. Acta Clin Belg. 1996;51(4):231-6. doi: 10.1080/22953337.1996.11718515. Acta Clin Belg. 1996. PMID: 8858888

7

Long-term pharmacologic doses of vitamin E only moderately affect the erythrocytes of patients with type 1 diabetes mellitus.

Manuel y Keenoy B, Shen H, Engelen W, Vertommen J, Van Dessel G, Lagrou A, De Leeuw I. Manuel y Keenoy B, et al. Among authors: engelen w. J Nutr. 2001 Jun;131(6):1723-30. doi: 10.1093/jn/131.6.1723. J Nutr. 2001. PMID: 11385059 Clinical Trial.

8

Effects of micronized fenofibrate and vitamin E on in vitro oxidation of lipoproteins in patients with type 1 diabetes mellitus.

Engelen W, Manuel-y-Keenoy B, Vertommen J, De Leeuw I, Van Gaal L. Engelen W, et al. Diabetes Metab. 2005 Apr;31(2):197-204. doi: 10.1016/s1262-3636(07)70186-6. Diabetes Metab. 2005. PMID: 15959426 Clinical Trial.

9

Are low magnesium levels in type 1 diabetes associated with electromyographical signs of polyneuropathy?

Engelen W, Bouten A, De Leeuw I, De Block C. Engelen W, et al. Magnes Res. 2000 Sep;13(3):197-203. Magnes Res. 2000. PMID: 11008927 Clinical Trial.

10

Long term magnesium supplementation influences favourably the natural evolution of neuropathy in Mg-depleted type 1 diabetic patients (T1dm).

De Leeuw I, Engelen W, De Block C, Van Gaal L. De Leeuw I, et al. Among authors: engelen w. Magnes Res. 2004 Jun;17(2):109-14. Magnes Res. 2004. PMID: 15319143 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters